CM
IRWD icon

Cercano Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cercano Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Hold
101,378
– – 0.06% 87
2026
Q1 		$356K Hold
101,378
– – 0.02% 108
2025
Q4 		$342K Hold
101,378
– – 0.01% 115
2025
Q3 		$133K Hold
101,378
– – 0.01% 151
2025
Q2 		$72.7K Hold
101,378
– – ﹤0.01% 150
2025
Q1 		$149K Hold
101,378
– – ﹤0.01% 146
2024
Q4 		$449K Hold
101,378
– – 0.01% 133
2024
Q3 		$418K Buy
+101,378
New +$545K 0.01% 117

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cercano Management's IRWD Position: Q2 2026 in Review

Cercano Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 101,378 shares worth $427K. The position accounts for 0.06% of the portfolio, ranked #87.

Cercano Management first reported a position in IRWD in Q3 2024 and has held it in 8 quarters since. The position peaked at $449K in Q4 2024. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Cercano Management held 101,378 shares of Ironwood Pharmaceuticals worth $427K as of Q2 2026.
  • Cercano Management left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
  • Ironwood Pharmaceuticals made up 0.06% of Cercano Management's portfolio in Q2 2026, its #87 holding.
  • Cercano Management first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Cercano Management's Ironwood Pharmaceuticals position peaked at $449K in Q4 2024.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Cercano Management's 13F filing for Q2 2026, filed 13 Aug 2026.